| For: | Ong CAJ, Lao-Sirieix P, Fitzgerald RC. Biomarkers in Barrett’s esophagus and esophageal adenocarcinoma: Predictors of progression and prognosis. World J Gastroenterol 2010; 16(45): 5669-5681 [PMID: 21128316 DOI: 10.3748/wjg.v16.i45.5669] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i45/5669.htm |
| Number | Citing Articles |
| 1 |
Romana Illig, Eckhard Klieser, Tobias Kiesslich, Daniel Neureiter. GERD—Barrett—Adenocarcinoma: Do We Have Suitable Prognostic and Predictive Molecular Markers?. Gastroenterology Research and Practice 2013; 2013 doi: 10.1155/2013/643084
|
| 2 |
Xiaojuan Pang, Yuxin Shu, Zhiyuan Niu, Wei Zheng, Haochen Wu, Yan Lu, Pingping Shen. PPARγ1 phosphorylation enhances proliferation and drug resistance in human fibrosarcoma cells. Experimental Cell Research 2014; 322(1) doi: 10.1016/j.yexcr.2014.01.010
|
| 3 |
Adam Frankel, Nicola Armour, Derek Nancarrow, Lutz Krause, Nicholas Hayward, Guy Lampe, B. Mark Smithers, Andrew Barbour. Genome‐wide analysis of esophageal adenocarcinoma yields specific copy number aberrations that correlate with prognosis. Genes, Chromosomes and Cancer 2014; 53(4) doi: 10.1002/gcc.22143
|
| 4 |
Ali H. Zaidi, Vanathi Gopalakrishnan, Pashtoon M. Kasi, Xuemei Zeng, Usha Malhotra, Jeya Balasubramanian, Shyam Visweswaran, Mai Sun, Melanie S. Flint, Jon M. Davison, Brian L. Hood, Thomas P. Conrads, Jacques J. Bergman, William L. Bigbee, Blair A. Jobe. Evaluation of a 4‐protein serum biomarker panel—biglycan, annexin‐A6, myeloperoxidase, and protein S100‐A9 (B‐AMP)—for the detection of esophageal adenocarcinoma. Cancer 2014; 120(24) doi: 10.1002/cncr.28963
|
| 5 |
Hao Chen, Yu Fang, Whitney Tevebaugh, Roy C. Orlando, Nicholas J. Shaheen, Xiaoxin Chen. Molecular Mechanisms of Barrett’s Esophagus. Digestive Diseases and Sciences 2011; 56(12) doi: 10.1007/s10620-011-1885-6
|
| 6 |
C M den Hoed, M van Blankenstein, J Dees, E J Kuipers. The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma. British Journal of Cancer 2011; 105(2) doi: 10.1038/bjc.2011.214
|
| 7 |
Richard G.H. Cotton, Rupert Langer, Trevor Leong, Jan Martinek, Vikash Sewram, Mark Smithers, Paul E. Swanson, You‐Lin Qiao, Harushi Udagawa, Masaki Ueno, Meng Wang, Wen‐Qiang Wei, Russell E. White. Coping with esophageal cancer approaches worldwide. Annals of the New York Academy of Sciences 2014; 1325(1) doi: 10.1111/nyas.12522
|
| 8 |
Nai-Jun Fan, Chun-Fang Gao, Chang-Song Wang, Guang Zhao, Jing-Jing Lv, Xiu-Li Wang, Guang-Hui Chu, Jian Yin, Dong-Hui Li, Xiao Chen, Xu-Tao Yuan, Nian-Long Meng. Identification of the up-regulation of TP-alpha, collagen alpha-1(VI) chain, and S100A9 in esophageal squamous cell carcinoma by a proteomic method. Journal of Proteomics 2012; 75(13) doi: 10.1016/j.jprot.2012.05.008
|
| 9 |
Vani Konda, Irving Waxman. Response to Ganz and Yapp. American Journal of Gastroenterology 2012; 107(11) doi: 10.1038/ajg.2012.310
|
| 10 |
VINCENZA CONTEDUCA, DOMENICO SANSONNO, GIUSEPPE INGRAVALLO, STEFANIA MARANGI, SABINO RUSSI, GIANFRANCO LAULETTA, FRANCO DAMMACCO. Barrett’s esophagus and esophageal cancer: An overview. International Journal of Oncology 2012; 41(2) doi: 10.3892/ijo.2012.1481
|
| 11 |
Tony E. Godfrey, Santhoshi Bandla, Virginia R. Litle, Jeffrey H. Peters. Shackelford's Surgery of the Alimentary Tract. 2013; doi: 10.1016/B978-1-4377-2206-2.00032-4
|
| 12 |
Chin-Ann J. Ong, Joel Shapiro, Katie S. Nason, Jon M. Davison, Xinxue Liu, Caryn Ross-Innes, Maria O'Donovan, Winand N.M. Dinjens, Katharina Biermann, Nicholas Shannon, Susannah Worster, Laura K.E. Schulz, James D. Luketich, Bas P.L. Wijnhoven, Richard H. Hardwick, Rebecca C. Fitzgerald. Three-Gene Immunohistochemical Panel Adds to Clinical Staging Algorithms to Predict Prognosis for Patients With Esophageal Adenocarcinoma. Journal of Clinical Oncology 2013; 31(12) doi: 10.1200/JCO.2012.45.9636
|
| 13 |
Gemma Maddalo, Matteo Fassan, Romilda Cardin, Marika Piciocchi, Filippo Marafatto, Massimo Rugge, Giovanni Zaninotto, Caterina Pozzan, Carlo Castoro, Alberto Ruol, Alessandra Biasiolo, Fabio Farinati. Squamous Cellular Carcinoma Antigen Serum Determination as a Biomarker of Barrett Esophagus and Esophageal Cancer. Journal of Clinical Gastroenterology 2018; 52(5) doi: 10.1097/MCG.0000000000000790
|
| 14 |
Lei Zhu, Lin Dong, Minghao Feng, Fugui Yang, Wenhao Jiang, Zhiyuan Huang, Fabing Liu, Lingwei Wang, Guangxue Wang, Qinchuan Li. Profiles of autophagy-related genes in esophageal adenocarcinoma. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07416-w
|
| 15 |
Sathisha Upparahalli Venkateshaiah, Chandra Sekhar Yadavalli, Hemanth Kumar Kandikattu, Sandeep Kumar, Lokanatha Oruganti, Anil Mishra. Molecules involved in the development of Barrett’s esophagus phenotype in chronic eosinophilic esophagitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2022; 323(1) doi: 10.1152/ajpgi.00321.2021
|
| 16 |
Chidi Amadi, Piers Gatenby. Barrett’s oesophagus: Current controversies. World Journal of Gastroenterology 2017; 23(28): 5051-5067 doi: 10.3748/wjg.v23.i28.5051
|
| 17 |
Florine Kastelein, Katharina Biermann, Ewout W Steyerberg, Joanne Verheij, Marit Kalisvaart, Leendert H J Looijenga, Hans A Stoop, Laurens Walter, Ernst J Kuipers, Manon C W Spaander, Marco J Bruno. Value of α‐methylacyl‐CoA racemase immunochemistry for predicting neoplastic progression in Barrett's oesophagus. Histopathology 2013; 63(5) doi: 10.1111/his.12216
|
| 18 |
Richard H. Lash, Thomas M. Deas, Frank H. Wians. Healthcare Cost of Over-Diagnosis of Low-Grade Dysplasia in Barrett’s Esophagus. Advances in Therapy 2016; 33(4) doi: 10.1007/s12325-016-0308-7
|
| 19 |
Tatiana Benaglia, Linda D. Sharples, Rebecca C. Fitzgerald, Georgios Lyratzopoulos. Health Benefits and Cost Effectiveness of Endoscopic and Nonendoscopic Cytosponge Screening for Barrett's Esophagus. Gastroenterology 2013; 144(1) doi: 10.1053/j.gastro.2012.09.060
|
| 20 |
C-I Geppert, P Rümmele, M Sarbia, R Langer, M Feith, L Morrison, E Pestova, R Schneider-Stock, A Hartmann, T T Rau. Multi-colour FISH in oesophageal adenocarcinoma—predictors of prognosis independent of stage and grade. British Journal of Cancer 2014; 110(12) doi: 10.1038/bjc.2014.238
|
| 21 |
Oliver M. Fisher, Reginald V.N. Lord. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set. 2019; doi: 10.1016/B978-0-323-40232-3.00032-7
|
| 22 |
Wei Chen, Kuan-Kei Kong, Xin-Ke Xu, Cheng Chen, Hui Li, Fang-Yu Wang, Xiao-Fang Peng, Zhan Zhang, Ping Li, Jun-Liang Li, Fang-Cheng Li. Downregulation of miR‑205 is associated with glioblastoma cell migration, invasion, and the epithelial-mesenchymal transition, by targeting ZEB1 via the Akt/mTOR signaling pathway. International Journal of Oncology 2017; doi: 10.3892/ijo.2017.4217
|
| 23 |
Helen G. Coleman, Shivaram Bhat, Brian T. Johnston, Damian McManus, Anna T. Gavin, Liam J. Murray. Tobacco Smoking Increases the Risk of High-Grade Dysplasia and Cancer Among Patients With Barrett's Esophagus. Gastroenterology 2012; 142(2) doi: 10.1053/j.gastro.2011.10.034
|
| 24 |
Nabil P. Rizk, Elliot L. Servais, Laura H. Tang, Camelia S. Sima, Hans Gerdes, Martin Fleisher, Valerie W. Rusch, Prasad S. Adusumilli. Tissue and Serum Mesothelin Are Potential Markers of Neoplastic Progression in Barrett's Associated Esophageal Adenocarcinoma. Cancer Epidemiology, Biomarkers & Prevention 2012; 21(3) doi: 10.1158/1055-9965.EPI-11-0993
|
| 25 |
Jiongyuan Xu, Lizhi Niu, Feng Mu, Shupeng Liu, Yin Leng, Mengtian Liao, Jianying Zeng, Fei Yao, Jibing Chen, Jialiang Li, Kecheng Xu. Percutaneous comprehensive cryoablation for metastatic esophageal cancer after failure of radical surgery. Cryobiology 2013; 67(3) doi: 10.1016/j.cryobiol.2013.10.004
|
| 26 |
Afzan Adam, Abdul Hadi Abd Rahman, Nor Samsiah Sani, Zaid Abdi Alkareem Alyessari, Nur Jumaadzan Zaleha Mamat, Basela Hasan. Epithelial Layer Estimation Using Curvatures and Textural Features for Dysplastic Tissue Detection. Computers, Materials & Continua 2021; 67(1) doi: 10.32604/cmc.2021.014599
|
| 27 |
Joana Cardoso, Marta Mesquita, António Dias Pereira, Mónica Bettencourt-Dias, Paula Chaves, José B. Pereira-Leal, John P. Lynch. CYR61 and TAZ Upregulation and Focal Epithelial to Mesenchymal Transition May Be Early Predictors of Barrett’s Esophagus Malignant Progression. PLOS ONE 2016; 11(9) doi: 10.1371/journal.pone.0161967
|
| 28 |
|
| 29 |
Deepa T. Patil, Robert D. Odze. Barrett's Esophagus and Associated Dysplasia. Gastroenterology Clinics of North America 2024; 53(1) doi: 10.1016/j.gtc.2023.11.002
|
| 30 |
Adam Frankel, Derek Nancarrow, Nicola Wayte, Andrew Barbour. Clinical issues in oesophageal adenocarcinoma: could DNA copy number hold the key?. ANZ Journal of Surgery 2012; 82(9) doi: 10.1111/j.1445-2197.2012.06144.x
|
| 31 |
Xiao-Fu Li, Zheng Jiang, Ying Gao, Chun-Xiang Li, Bao-Zhong Shen. Combination of three-gene immunohistochemical panel and magnetic resonance imaging-detected extramural vascular invasion to assess prognosis in non-advanced rectal cancer patients. World Journal of Gastroenterology 2016; 22(38): 8576-8583 doi: 10.3748/wjg.v22.i38.8576
|
| 32 |
Ishaan Maitra, Ravindra Sudhachandra Date, Francis Luke Martin. Towards screening Barrett’s oesophagus: current guidelines, imaging modalities and future developments. Clinical Journal of Gastroenterology 2020; 13(5) doi: 10.1007/s12328-020-01135-2
|
| 33 |
Danielle M. Battle, Sanjika Dias Gunasekara, Graeme R. Watson, Eltayeb Mohamed Ahmed, Colin G. Saysell, Naveed Altaf, Abayomi L. Sanusi, Phanibhushana C. Munipalle, David Scoones, Julie Walker, Yks Viswanath, Adam M. Benham. Expression of the Endoplasmic Reticulum Oxidoreductase Ero1α in Gastro-Intestinal Cancer Reveals a Link Between Homocysteine and Oxidative Protein Folding. Antioxidants & Redox Signaling 2013; 19(1) doi: 10.1089/ars.2012.4651
|
| 34 |
A.G. Neto, R.A. Hickman, A. Khan, C. Nossa, Z. Pei. The Microbiota in Gastrointestinal Pathophysiology. 2017; doi: 10.1016/B978-0-12-804024-9.00001-X
|
| 35 |
Santhoshi Bandla, Jeffrey H. Peters, David Ruff, Shiaw-Min Chen, Chieh-Yuan Li, Kunchang Song, Kimberly Thoms, Virginia R. Litle, Thomas Watson, Nikita Chapurin, Michal Lada, Arjun Pennathur, James D. Luketich, Derick Peterson, Austin Dulak, Lin Lin, Adam Bass, David G. Beer, Tony E. Godfrey, Zhongren Zhou. Comparison of Cancer-Associated Genetic Abnormalities in Columnar-Lined Esophagus Tissues With and Without Goblet Cells. Annals of Surgery 2014; 260(1) doi: 10.1097/SLA.0000000000000424
|
| 36 |
L H McCormick Matthews, F Noble, J Tod, E Jaynes, S Harris, J N Primrose, C Ottensmeier, G J Thomas, T J Underwood. Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma. British Journal of Cancer 2015; 113(1) doi: 10.1038/bjc.2015.179
|
| 37 |
Roger Yazbeck, Simone E Jaenisch, David I Watson. From blood to breath: New horizons for esophageal cancer biomarkers. World Journal of Gastroenterology 2016; 22(46): 10077-10083 doi: 10.3748/wjg.v22.i46.10077
|
| 38 |
H. Ece Arslan Ozcan, Turgut Anuk, Ozkan Ozden. Expression profile and cellular localizations of mucin proteins, CK7, and cytoplasmic p27 in Barrett’s esophagus and esophageal adenocarcinoma. Advances in Medical Sciences 2018; 63(2) doi: 10.1016/j.advms.2018.04.002
|
| 39 |
Miklós Máté, Béla Molnár. A Relation Between Cell Cycle and Intestinal Metaplasia in Oesophageal Biopsies Using Optical and Digital Microscopy. Pathology & Oncology Research 2015; 21(3) doi: 10.1007/s12253-014-9873-8
|
| 40 |
|
| 41 |
Zeeshan Ramzan, Ammar B Nassri, Sergio Huerta. The use of imaging and biomarkers in diagnosing Barrett’s esophagus and predicting the risk of neoplastic progression. Expert Review of Molecular Diagnostics 2014; 14(5) doi: 10.1586/14737159.2014.919856
|
| 42 |
Anna Mokrowiecka, Lothar Veits, Christina Falkeis, Jacek Musial, Radzislaw Kordek, Mariusz Lochowski, Jozef Kozak, Agnieszka Wierzchniewska-Lawska, Michael Vieth, Ewa Malecka-Panas. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa—Barrett’s esophagus—early esophageal adenocarcinoma—advanced esophageal adenocarcinoma sequence. Pathology - Research and Practice 2017; 213(3) doi: 10.1016/j.prp.2016.12.018
|
| 43 |
Irina Kalatskaya. Overview of major molecular alterations during progression from Barrett's esophagus to esophageal adenocarcinoma. Annals of the New York Academy of Sciences 2016; 1381(1) doi: 10.1111/nyas.13134
|
| 44 |
Marilanda Ferreira Bellini, Aline Cristina Targa Cadamuro, Maysa Succi, Marcela Alcântara Proença, Ana Elizabete Silva. Alterations of theTP53Gene in Gastric and Esophageal Carcinogenesis. Journal of Biomedicine and Biotechnology 2012; 2012 doi: 10.1155/2012/891961
|
| 45 |
D. V. Danilov, A. G. Shuleshova, K. A. Bondareva. The current state of the art in the treatment of erosive esophagitis. Dokazatel'naya gastroenterologiya 2017; 6(1) doi: 10.17116/dokgastro20176126-30
|
| 46 |
Chaohui Wu, Minjie Li, Chao Hu, Hongbing Duan. Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma. Molecular Biology Reports 2014; 41(3) doi: 10.1007/s11033-013-2970-z
|
| 47 |
Hugo Ford, Ioannis Gounaris. Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinoma. Therapeutic Advances in Gastroenterology 2015; 8(4) doi: 10.1177/1756283X15585468
|
| 48 |
Anne-Marie Byrne, Spiros Bekiaris, Gina Duggan, David Prichard, Murat Kirca, Stephen Finn, John V Reynolds, Dermot Kelleher, Aideen Long. Golgi phosphoprotein 2 (GOLPH2) is a novel bile acid-responsive modulator of oesophageal cell migration and invasion. British Journal of Cancer 2015; 113(9) doi: 10.1038/bjc.2015.350
|